FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006121313> ?p ?o ?g. }

• W2006121313 endingPage "34" @default.
• W2006121313 startingPage "27" @default.
• W2006121313 abstract "Objective: The aim of this study was to investigate the effect of time on pharmacokinetic (PK) parameters of mycophenolic acid (MPA) in the early post-transplant period in kidney recipients. MPA is the active metabolite of mycophenolate mofetil (MMF), which was introduced into clinical practice ten years ago. Method: Mycophenolate mofetil was co-administered with cyclosporin (CsA) in a subgroup of 23 patients and with tacrolimus (Tac) in a subgroup of 10 patients. MPA plasma concentration profiles were measured by a validated high performance liquid chromatography method 1 week, 2 and 3 months after transplantation. Results: Despite a comparable MMF dose, a large inter-patient variability in both MPA area under the curve (AUC) from 0 to 12 h (range 10·03–135·4 μg h/mL) and in predose concentrations (0·31–6·09 μg/mL) was observed. Patients with AUC > 35 μg h/mL showed better (P < 0·1) renal function than patients with AUC < 20 μg h/mL (mean creatinine concentration 1·48 ± 0·12 vs. 3·35 ± 0·4 mg/dL respectively). The total MPA trough and AUC did not correlate with biochemical parameters: leucocyte cell count and haematocrit. A higher trough level of the metabolite MPA glucuronide (MPAG) in the 1 week after transplantation was found when compared with the 3-month level (mean 150·1 ± 146·7; range 17·1 to 560 vs. 75·8 ± 40·0; range 27·3 to 174·2 μg/mL). The concentration of MPA, and MPA AUC values were significantly lower in patients receiving MMF and CsA than those receiving MMF and Tac during all three periods studied (P < 0·02). The influence of C0 and MPA AUC values on the risk of graft rejection was investigated using receiver operating characteristic (ROC) curve analysis. The area under the ROC curve for AUC was 0·847, whereas that of C0 was 0·632. Conclusions: The MPA AUC0−12h appeared to be the more effective PK parameter for predicting acute rejection. We recommend that routine MPA and MPAG therapeutic drug level monitoring should be an important part of MMF therapy." @default.
• W2006121313 created "2016-06-24" @default.
• W2006121313 creator A5018283980 @default.
• W2006121313 creator A5032872429 @default.
• W2006121313 creator A5052052294 @default.
• W2006121313 creator A5063202681 @default.
• W2006121313 creator A5063929021 @default.
• W2006121313 creator A5087525266 @default.
• W2006121313 date "2006-02-01" @default.
• W2006121313 modified "2023-10-03" @default.
• W2006121313 title "Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant" @default.
• W2006121313 cites W1891570058 @default.
• W2006121313 cites W1971018450 @default.
• W2006121313 cites W1977126062 @default.
• W2006121313 cites W1981535286 @default.
• W2006121313 cites W1992509804 @default.
• W2006121313 cites W1994092210 @default.
• W2006121313 cites W2006198853 @default.
• W2006121313 cites W2008380441 @default.
• W2006121313 cites W2008808603 @default.
• W2006121313 cites W2022411944 @default.
• W2006121313 cites W2025501899 @default.
• W2006121313 cites W2032807691 @default.
• W2006121313 cites W2036991479 @default.
• W2006121313 cites W2038909026 @default.
• W2006121313 cites W2046582946 @default.
• W2006121313 cites W2056054156 @default.
• W2006121313 cites W2069790510 @default.
• W2006121313 cites W2079955261 @default.
• W2006121313 cites W2081993545 @default.
• W2006121313 cites W2083923703 @default.
• W2006121313 cites W2116626206 @default.
• W2006121313 cites W2146676538 @default.
• W2006121313 cites W2149093312 @default.
• W2006121313 cites W2150895558 @default.
• W2006121313 cites W2315537783 @default.
• W2006121313 cites W2321360678 @default.
• W2006121313 cites W2326099081 @default.
• W2006121313 cites W2409639874 @default.
• W2006121313 cites W66541766 @default.
• W2006121313 doi "https://doi.org/10.1111/j.1365-2710.2006.00713.x" @default.
• W2006121313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16476117" @default.
• W2006121313 hasPublicationYear "2006" @default.
• W2006121313 type Work @default.
• W2006121313 sameAs 2006121313 @default.
• W2006121313 citedByCount "44" @default.
• W2006121313 countsByYear W20061213132012 @default.
• W2006121313 countsByYear W20061213132013 @default.
• W2006121313 countsByYear W20061213132014 @default.
• W2006121313 countsByYear W20061213132015 @default.
• W2006121313 countsByYear W20061213132016 @default.
• W2006121313 countsByYear W20061213132018 @default.
• W2006121313 countsByYear W20061213132019 @default.
• W2006121313 countsByYear W20061213132020 @default.
• W2006121313 countsByYear W20061213132021 @default.
• W2006121313 crossrefType "journal-article" @default.
• W2006121313 hasAuthorship W2006121313A5018283980 @default.
• W2006121313 hasAuthorship W2006121313A5032872429 @default.
• W2006121313 hasAuthorship W2006121313A5052052294 @default.
• W2006121313 hasAuthorship W2006121313A5063202681 @default.
• W2006121313 hasAuthorship W2006121313A5063929021 @default.
• W2006121313 hasAuthorship W2006121313A5087525266 @default.
• W2006121313 hasBestOaLocation W20061213131 @default.
• W2006121313 hasConcept C112705442 @default.
• W2006121313 hasConcept C126322002 @default.
• W2006121313 hasConcept C126894567 @default.
• W2006121313 hasConcept C149151106 @default.
• W2006121313 hasConcept C159641895 @default.
• W2006121313 hasConcept C185592680 @default.
• W2006121313 hasConcept C2777477808 @default.
• W2006121313 hasConcept C2778033501 @default.
• W2006121313 hasConcept C2780303639 @default.
• W2006121313 hasConcept C2780306776 @default.
• W2006121313 hasConcept C2909675724 @default.
• W2006121313 hasConcept C2909935303 @default.
• W2006121313 hasConcept C2910800852 @default.
• W2006121313 hasConcept C2911091166 @default.
• W2006121313 hasConcept C31785415 @default.
• W2006121313 hasConcept C71924100 @default.
• W2006121313 hasConcept C76318530 @default.
• W2006121313 hasConcept C90924648 @default.
• W2006121313 hasConcept C98274493 @default.
• W2006121313 hasConceptScore W2006121313C112705442 @default.
• W2006121313 hasConceptScore W2006121313C126322002 @default.
• W2006121313 hasConceptScore W2006121313C126894567 @default.
• W2006121313 hasConceptScore W2006121313C149151106 @default.
• W2006121313 hasConceptScore W2006121313C159641895 @default.
• W2006121313 hasConceptScore W2006121313C185592680 @default.
• W2006121313 hasConceptScore W2006121313C2777477808 @default.
• W2006121313 hasConceptScore W2006121313C2778033501 @default.
• W2006121313 hasConceptScore W2006121313C2780303639 @default.
• W2006121313 hasConceptScore W2006121313C2780306776 @default.
• W2006121313 hasConceptScore W2006121313C2909675724 @default.
• W2006121313 hasConceptScore W2006121313C2909935303 @default.
• W2006121313 hasConceptScore W2006121313C2910800852 @default.
• W2006121313 hasConceptScore W2006121313C2911091166 @default.
• W2006121313 hasConceptScore W2006121313C31785415 @default.
• W2006121313 hasConceptScore W2006121313C71924100 @default.

• next